US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

OPUS GENETICS INC

5.28

-0.1300-2.40%

Pre-market: 5.23-0.0500-0.95%06:48 EDT

Volume:1.53M

Turnover:8.18M

Market Cap:439.27M

PE:-4.09

High:5.62

Open:5.46

Low:5.23

Close:5.41

52wk High:7.07

52wk Low:1.41

Shares:83.20M

Float Shares:64.45M

Volume Ratio:0.42

T/O Rate:2.38%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.2925

EPS(LYR):-0.8000

ROE:-4796.52%

ROA:-48.06%

PB:-33.83

PE(LYR):-6.60

Loading ...

Overview Company News Filings

Opus Genetics assumed with a Buy at Chardan

Opus Genetics Price Target Maintained With a $12.00/Share by BTIG

Opus Genetics hosts R&D Science Forum highlighting inherited retinal disease gene therapy pipeline

Opus Genetics Price Target Maintained With a $11.00/Share by Citizens

Opus Genetics - Files for Resale of up to 2.68 Mln Shares of Common Stock by Selling Stockholders - SEC Filing

THOMSON REUTERS

Opus Genetics Initiated at Buy by Guggenheim

Guggenheim Initiates Opus Genetics at Buy With $16 Price Target

MT Newswires Live

Opus Genetics publishes investor presentation on gene therapy pipeline for rare inherited retinal diseases

BRIEF-Opus Genetics Reports Inducement Grants Under Nasdaq Listing Rule

Opus Genetics grants options for 698,000 shares to 10 new hires under inducement plan

Opus Genetics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS

Opus Genetics presents at Jefferies Global Healthcare Conference

Opus Genetics Initiated at Outperform by Leerink Partners

Leerink Partners Initiates Opus Genetics at Outperform With $10 Price Target

MT Newswires Live

Opus Genetics initiated with an Outperform at Leerink

Opus Genetics Inc : Leerink Partners Initiates Coverage With Outperform Rating; Target Price $10

THOMSON REUTERS

Foundation Fighting Blindness Retinal Degeneration Fund sells Opus Genetics shares worth $7.4 million

LifeSci Capital Sticks to Its Buy Rating for Opus Genetics (IRD)

Cantor Fitzgerald Sticks to Its Buy Rating for Opus Genetics (IRD)

Opus Genetics (IRD) Q1 Loss Of US$65.5 Million Intensifies Bearish Community Narratives

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/IRD/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"IRD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IRD\",,,,,undefined,":{"symbol":"IRD","market":"US","secType":"STK","nameCN":"OPUS GENETICS INC","latestPrice":5.28,"timestamp":1789675200000,"preClose":5.41,"halted":0,"volume":1531806,"hourTrading":{"tag":"盘前","latestPrice":5.23,"preClose":5.28,"latestTime":"06:48 EDT","volume":630,"amount":3295.17846,"timestamp":1789728530428,"change":-0.05,"changeRate":-0.00947,"amplitude":0.017045},"delay":0,"changeRate":-0.024029574861367815,"floatShares":64451400,"shares":83195823,"eps":-1.292468,"marketStatus":"Pre-Mkt","change":-0.13,"latestTime":"09-18 06:51:45 EDT","open":5.46,"high":5.62,"low":5.23,"amount":8184084.079008001,"amplitude":0.072089,"askPrice":5.29,"askSize":283,"bidPrice":5.2,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.292468,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789738200000},"marketStatusCode":1,"adr":0,"listingDate":1100235600000,"exchange":"NASDAQ","adjPreClose":5.28,"preHourTrading":{"tag":"盘前","latestPrice":5.23,"preClose":5.28,"latestTime":"06:48 EDT","volume":630,"amount":3295.17846,"timestamp":1789728530428,"change":-0.05,"changeRate":-0.00947,"amplitude":0.017045},"postHourTrading":{"tag":"盘后","latestPrice":5.28,"preClose":5.28,"latestTime":"19:52 EDT","volume":14971,"amount":79055.6433,"timestamp":1789689137171,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.42373720140376414,"impliedVol":1.289,"impliedVolPercentile":0.344},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IRD\",,,,,undefined,":{"symbol":"IRD","floatShares":64451400,"roa":"-48.06%","roe":"-4796.52%","lyrEps":-0.8,"volumeRatio":0.42373720140376414,"shares":83195823,"dividePrice":0,"high":5.62,"amplitude":0.072089,"preClose":5.41,"low":5.23,"week52Low":1.41,"pbRate":"-33.83","psRate":"44.57","week52High":7.07,"institutionHeld":0,"latestPrice":5.28,"committee":-0.477807,"eps":-1.292468,"divideRate":0,"volume":1531806,"delay":0,"ttmEps":-1.292468,"open":5.46,"prevYearClose":2.01,"prevWeekClose":6.04,"prevMonthClose":3.62,"prevQuarterClose":4.11,"fiveDayClose":6.07,"twentyDayClose":4.07,"sixtyDayClose":4.08},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IRD\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-06","symbol":"IRD","fiscalQuarterEnding":"2026/06","expectedEps":-0.15,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1785988800000,"reportTimeType":"pre","actualEps":-0.14},{"market":"US","date":"2026-05-12","symbol":"IRD","fiscalQuarterEnding":"2026/03","expectedEps":-0.16,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778558400000,"reportTimeType":"pre","actualEps":-0.75},{"market":"US","date":"2026-03-10","symbol":"IRD","fiscalQuarterEnding":"2025/12","expectedEps":-0.11,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1773115200000,"reportTimeType":"pre","actualEps":-0.14},{"market":"US","date":"2025-11-12","symbol":"IRD","fiscalQuarterEnding":"2025/09","expectedEps":-0.14,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"pre","actualEps":-0.12},{"market":"US","date":"2025-08-13","symbol":"IRD","fiscalQuarterEnding":"2025/06","expectedEps":-0.25,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1755057600000,"reportTimeType":"post","actualEps":-0.12}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IRD\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IRD\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2778,"buy":0.7222,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.7222,"analysts":18,"updateTime":1785384000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/IRD\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"IRD","date":"2026-09-16","current":-4.085208,"percent":0.108742,"low":-8.249622,"twenty":-3.09043,"median":-2.022322,"eighty":-1.135376,"high":-0.560128,"avg":-2.417112,"sd":1.788265,"marketCap":484199689},"quantilePoints":[{"date":"2024-10-31","current":-2.785848,"twenty":-2.857166,"median":-2.64666,"eighty":-2.37374,"marketCap":39294383},{"date":"2024-11-08","current":-2.429259,"twenty":-2.692243,"median":-2.607554,"eighty":-2.476187,"marketCap":34264702},{"date":"2024-11-15","current":-1.225421,"twenty":-2.616468,"median":-2.568551,"eighty":-2.326813,"marketCap":33321637},{"date":"2024-11-22","current":-1.142487,"twenty":-2.607554,"median":-2.49612,"eighty":-1.192247,"marketCap":31066518},{"date":"2024-11-29","current":-1.288651,"twenty":-2.607554,"median":-2.173143,"eighty":-1.193702,"marketCap":35040987},{"date":"2024-12-06","current":-1.323479,"twenty":-2.603096,"median":-1.364112,"eighty":-1.225421,"marketCap":35988040},{"date":"2024-12-13","current":-1.288651,"twenty":-2.574123,"median":-1.335088,"eighty":-1.234669,"marketCap":35040987},{"date":"2024-12-20","current":-1.14597,"twenty":-2.527405,"median":-1.303163,"eighty":-1.16559,"marketCap":31161223},{"date":"2024-12-27","current":-1.253822,"twenty":-2.505202,"median":-1.288651,"eighty":-1.163268,"marketCap":34093933},{"date":"2025-01-03","current":-1.462793,"twenty":-2.49612,"median":-1.294455,"eighty":-1.172556,"marketCap":39776255},{"date":"2025-01-10","current":-1.683372,"twenty":-2.442631,"median":-1.320577,"eighty":-1.181843,"marketCap":45774262},{"date":"2025-01-17","current":-1.346698,"twenty":-2.224366,"median":-1.346698,"eighty":-1.20274,"marketCap":36619410},{"date":"2025-01-24","current":-1.335088,"twenty":-1.87928,"median":-1.335088,"eighty":-1.207384,"marketCap":36303725},{"date":"2025-01-31","current":-1.288651,"twenty":-1.676407,"median":-1.329284,"eighty":-1.218206,"marketCap":35040987},{"date":"2025-02-07","current":-1.416355,"twenty":-1.657832,"median":-1.323479,"eighty":-1.225421,"marketCap":38513517},{"date":"2025-02-14","current":-1.335088,"twenty":-1.648544,"median":-1.323479,"eighty":-1.239294,"marketCap":36303725},{"date":"2025-02-21","current":-1.288651,"twenty":-1.616038,"median":-1.323479,"eighty":-1.250654,"marketCap":35040987},{"date":"2025-02-28","current":-1.207384,"twenty":-1.525484,"median":-1.317674,"eighty":-1.232138,"marketCap":32831195},{"date":"2025-03-07","current":-1.160946,"twenty":-1.444218,"median":-1.31187,"eighty":-1.207384,"marketCap":31568457},{"date":"2025-03-14","current":-1.07968,"twenty":-1.411711,"median":-1.30026,"eighty":-1.1772,"marketCap":29358665},{"date":"2025-03-21","current":-1.335088,"twenty":-1.404745,"median":-1.30026,"eighty":-1.16559,"marketCap":36303725},{"date":"2025-03-28","current":-1.637559,"twenty":-1.525484,"median":-1.31187,"eighty":-1.1772,"marketCap":44528506},{"date":"2025-04-04","current":-0.76585,"twenty":-1.525484,"median":-1.306065,"eighty":-1.160946,"marketCap":44060874},{"date":"2025-04-11","current":-0.564318,"twenty":-1.462793,"median":-1.288651,"eighty":-1.14388,"marketCap":32466352},{"date":"2025-04-17","current":-0.581158,"twenty":-1.453505,"median":-1.288651,"eighty":-1.129154,"marketCap":33435158},{"date":"2025-04-25","current":-0.632466,"twenty":-1.414033,"median":-1.288651,"eighty":-1.081468,"marketCap":36387058},{"date":"2025-05-02","current":-0.741567,"twenty":-1.404745,"median":-1.288651,"eighty":-1.054291,"marketCap":42663825},{"date":"2025-05-09","current":-0.787263,"twenty":-1.404745,"median":-1.277041,"eighty":-0.791089,"marketCap":45292790},{"date":"2025-05-16","current":-0.737114,"twenty":-1.402423,"median":-1.253822,"eighty":-0.755291,"marketCap":43209631},{"date":"2025-05-23","current":-0.783669,"twenty":-1.393136,"median":-1.253822,"eighty":-0.759832,"marketCap":45938661},{"date":"2025-05-30","current":-0.771642,"twenty":-1.393136,"median":-1.251182,"eighty":-0.76585,"marketCap":45233661},{"date":"2025-06-06","current":-1.017762,"twenty":-1.393136,"median":-1.225421,"eighty":-0.767335,"marketCap":59661197},{"date":"2025-06-13","current":-1.009213,"twenty":-1.381526,"median":-1.207384,"eighty":-0.771254,"marketCap":59160042},{"date":"2025-06-20","current":-0.947842,"twenty":-1.372239,"median":-1.207384,"eighty":-0.771564,"marketCap":55562472},{"date":"2025-06-27","current":-1.038117,"twenty":-1.360629,"median":-1.184165,"eighty":-0.771642,"marketCap":60854420},{"date":"2025-07-03","current":-1.017762,"twenty":-1.358307,"median":-1.160946,"eighty":-0.77653,"marketCap":59661197},{"date":"2025-07-11","current":-1.139893,"twenty":-1.351342,"median":-1.160017,"eighty":-0.782117,"marketCap":66820540},{"date":"2025-07-18","current":-1.185692,"twenty":-1.346698,"median":-1.152239,"eighty":-0.783669,"marketCap":69505294},{"date":"2025-07-25","current":-1.231492,"twenty":-1.339732,"median":-1.160017,"eighty":-0.783669,"marketCap":72190048},{"date":"2025-08-01","current":-1.129716,"twenty":-1.335088,"median":-1.160248,"eighty":-0.785825,"marketCap":66223928},{"date":"2025-08-08","current":-1.10936,"twenty":-1.335088,"median":-1.151155,"eighty":-0.789762,"marketCap":65030704},{"date":"2025-08-15","current":-1.213067,"twenty":-1.335088,"median":-1.150071,"eighty":-0.791428,"marketCap":70691504},{"date":"2025-08-22","current":-1.177087,"twenty":-1.335088,"median":-1.151155,"eighty":-0.791428,"marketCap":68594722},{"date":"2025-08-29","current":-1.287434,"twenty":-1.335088,"median":-1.160248,"eighty":-0.791428,"marketCap":75025207},{"date":"2025-09-05","current":-1.384803,"twenty":-1.335088,"median":-1.160946,"eighty":-0.797415,"marketCap":80699383},{"date":"2025-09-12","current":-1.525447,"twenty":-1.342054,"median":-1.174821,"eighty":-0.822134,"marketCap":88895414},{"date":"2025-09-19","current":-1.611997,"twenty":-1.365273,"median":-1.182227,"eighty":-0.876364,"marketCap":93939125},{"date":"2025-09-26","current":-1.860829,"twenty":-1.384803,"median":-1.184928,"eighty":-0.929339,"marketCap":108439795},{"date":"2025-10-03","current":-1.947379,"twenty":-1.400101,"median":-1.195775,"eighty":-0.939944,"marketCap":113483507},{"date":"2025-10-10","current":-2.152936,"twenty":-1.42988,"median":-1.207384,"eighty":-0.94314,"marketCap":125462322},{"date":"2025-10-17","current":-2.174573,"twenty":-1.477844,"median":-1.207384,"eighty":-0.951343,"marketCap":126723249},{"date":"2025-10-24","current":-2.163754,"twenty":-1.521119,"median":-1.217191,"eighty":-0.957164,"marketCap":126092786},{"date":"2025-10-31","current":-2.131298,"twenty":-1.627334,"median":-1.225421,"eighty":-0.958345,"marketCap":124201394},{"date":"2025-11-07","current":-2.196211,"twenty":-1.661499,"median":-1.23256,"eighty":-0.960734,"marketCap":127984177},{"date":"2025-11-14","current":-2.001473,"twenty":-1.74585,"median":-1.242213,"eighty":-0.964942,"marketCap":116635827},{"date":"2025-11-21","current":-1.951541,"twenty":-1.828372,"median":-1.253822,"eighty":-0.975077,"marketCap":133100921},{"date":"2025-11-28","current":-2.153773,"twenty":-1.878321,"median":-1.253822,"eighty":-0.98727,"marketCap":146893763},{"date":"2025-12-05","current":-2.254889,"twenty":-1.925381,"median":-1.265432,"eighty":-0.988735,"marketCap":153790183},{"date":"2025-12-12","current":-2.467233,"twenty":-1.950709,"median":-1.277041,"eighty":-0.996674,"marketCap":168272667},{"date":"2025-12-19","current":-2.002099,"twenty":-2.002099,"median":-1.288651,"eighty":-1.007767,"marketCap":136549131},{"date":"2025-12-26","current":-2.062768,"twenty":-2.022322,"median":-1.288651,"eighty":-1.0085,"marketCap":140686984},{"date":"2026-01-02","current":-2.032433,"twenty":-2.02248,"median":-1.288651,"eighty":-1.00907,"marketCap":138618058},{"date":"2026-01-09","current":-2.022322,"twenty":-2.035652,"median":-1.288651,"eighty":-1.009619,"marketCap":137928416},{"date":"2026-01-16","current":-2.103215,"twenty":-2.062768,"median":-1.30026,"eighty":-1.016154,"marketCap":143445552},{"date":"2026-01-23","current":-2.527902,"twenty":-2.079519,"median":-1.303662,"eighty":-1.017762,"marketCap":172410520},{"date":"2026-01-30","current":-2.527902,"twenty":-2.105793,"median":-1.31187,"eighty":-1.017762,"marketCap":172410520},{"date":"2026-02-06","current":-2.608795,"twenty":-2.126582,"median":-1.317674,"eighty":-1.019861,"marketCap":177927656},{"date":"2026-02-13","current":-3.427836,"twenty":-2.136977,"median":-1.323479,"eighty":-1.031375,"marketCap":233788665},{"date":"2026-02-20","current":-3.609844,"twenty":-2.149226,"median":-1.323479,"eighty":-1.038117,"marketCap":246202222},{"date":"2026-02-27","current":-3.630068,"twenty":-2.153773,"median":-1.330709,"eighty":-1.044184,"marketCap":247581506},{"date":"2026-03-06","current":-4.823238,"twenty":-2.163754,"median":-1.335088,"eighty":-1.055298,"marketCap":328959272},{"date":"2026-03-13","current":-6.821589,"twenty":-2.163832,"median":-1.335088,"eighty":-1.05838,"marketCap":338289413},{"date":"2026-03-20","current":-6.571003,"twenty":-2.174573,"median":-1.340893,"eighty":-1.062543,"marketCap":325862626},{"date":"2026-03-27","current":-6.48492,"twenty":-2.196211,"median":-1.358307,"eighty":-1.072721,"marketCap":321593683},{"date":"2026-04-02","current":-6.728822,"twenty":-2.279157,"median":-1.369917,"eighty":-1.078827,"marketCap":333689021},{"date":"2026-04-10","current":-7.890943,"twenty":-2.31549,"median":-1.383164,"eighty":-1.078974,"marketCap":391319747},{"date":"2026-04-17","current":-8.249622,"twenty":-2.347317,"median":-1.393136,"eighty":-1.079587,"marketCap":409107008},{"date":"2026-04-24","current":-7.474875,"twenty":-2.424764,"median":-1.39894,"eighty":-1.079843,"marketCap":370686524},{"date":"2026-05-01","current":-7.357517,"twenty":-2.49456,"median":-1.404745,"eighty":-1.081468,"marketCap":364866631},{"date":"2026-05-08","current":-7.717474,"twenty":-2.527902,"median":-1.450845,"eighty":-1.086096,"marketCap":382717249},{"date":"2026-05-15","current":-3.318654,"twenty":-2.605325,"median":-1.471353,"eighty":-1.089005,"marketCap":354870285},{"date":"2026-05-22","current":-2.864592,"twenty":-2.625631,"median":-1.50381,"eighty":-1.089833,"marketCap":306316604},{"date":"2026-05-29","current":-2.804496,"twenty":-2.764432,"median":-1.520037,"eighty":-1.093147,"marketCap":299890382},{"date":"2026-06-05","current":-3.098301,"twenty":-2.804496,"median":-1.567278,"eighty":-1.099183,"marketCap":331307470},{"date":"2026-06-12","current":-2.976252,"twenty":-2.841362,"median":-1.641006,"eighty":-1.10936,"marketCap":318256557},{"date":"2026-06-18","current":-3.09043,"twenty":-2.862186,"median":-1.648544,"eighty":-1.10936,"marketCap":330465888},{"date":"2026-06-26","current":-2.831626,"twenty":-2.921273,"median":-1.671763,"eighty":-1.117502,"marketCap":302791405},{"date":"2026-07-02","current":-3.181773,"twenty":-2.964753,"median":-1.703207,"eighty":-1.119538,"marketCap":340233353},{"date":"2026-07-10","current":-3.103979,"twenty":-3.005472,"median":-1.779688,"eighty":-1.123486,"marketCap":331914656},{"date":"2026-07-17","current":-2.5326,"twenty":-2.998741,"median":-1.85001,"eighty":-1.127372,"marketCap":270815938},{"date":"2026-07-24","current":-2.254631,"twenty":-2.977774,"median":-1.874663,"eighty":-1.129113,"marketCap":241092238},{"date":"2026-07-31","current":-2.964995,"twenty":-2.973207,"median":-1.900983,"eighty":-1.129716,"marketCap":317052806},{"date":"2026-08-07","current":-2.854241,"twenty":-2.967182,"median":-1.931317,"eighty":-1.129716,"marketCap":307144906},{"date":"2026-08-14","current":-2.87602,"twenty":-2.967182,"median":-1.947379,"eighty":-1.129716,"marketCap":309488461},{"date":"2026-08-21","current":-3.185269,"twenty":-2.973207,"median":-1.951541,"eighty":-1.129716,"marketCap":342766790},{"date":"2026-08-28","current":-2.976526,"twenty":-2.991855,"median":-1.986619,"eighty":-1.13016,"marketCap":320303918},{"date":"2026-09-04","current":-3.556368,"twenty":-3.015947,"median":-2.002099,"eighty":-1.13167,"marketCap":382700785},{"date":"2026-09-11","current":-4.69286,"twenty":-3.069117,"median":-2.01221,"eighty":-1.133546,"marketCap":504998645},{"date":"2026-09-16","current":-4.499579,"twenty":-3.09043,"median":-2.022322,"eighty":-1.135376,"marketCap":484199689}],"updateTime":1789715131070},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IRD\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2644778736","title":"Opus Genetics assumed with a Buy at Chardan","url":"https://stock-news.laohu8.com/highlight/detail?id=2644778736","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644778736?lang=en_us&edition=fundamental","pubTime":"2026-06-18 08:25","pubTimestamp":1781742307,"startTime":"0","endTime":"0","summary":"Chardan assumed coverage of Opus Genetics (IRD) with a Buy rating and a price target of $13, up from $11. The company’s Virtual R&D Science Forum l...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/opus-genetics-assumed-with-a-buy-at-chardan-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/opus-genetics-assumed-with-a-buy-at-chardan-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4139","IRD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644627714","title":"Opus Genetics Price Target Maintained With a $12.00/Share by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2644627714","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644627714?lang=en_us&edition=fundamental","pubTime":"2026-06-17 16:54","pubTimestamp":1781686440,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/IRD/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 17, 2026 04:54 ET (08:54 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IRD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644476724","title":"Opus Genetics hosts R&D Science Forum highlighting inherited retinal disease gene therapy pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2644476724","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644476724?lang=en_us&edition=fundamental","pubTime":"2026-06-17 04:05","pubTimestamp":1781640339,"startTime":"0","endTime":"0","summary":"Management outlined five programs with four clinical readouts targeted in 2027, with RDH12, MERTK, RHO trials slated from Q4 2026.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260616:nNDL4P4NQV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314104364.USD","IRD","IE00B3QW5Z07.USD","IE00BKPKM429.USD","SG9999014021.USD","BK4139","LU2095319765.USD","SG9999014039.USD","IE00BN0W2V16.EUR","BK4588","BK4112","IE00B64PRP62.GBP","IE00BGHQF748.EUR","NDAQ","SG9999014005.SGD","LU2210150020.SGD","IE00BN0W2T93.GBP","LU2210149790.SGD","IE00BN0W2W23.USD","SG9999014013.SGD","BK4007","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643013152","title":"Opus Genetics Price Target Maintained With a $11.00/Share by Citizens","url":"https://stock-news.laohu8.com/highlight/detail?id=2643013152","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643013152?lang=en_us&edition=fundamental","pubTime":"2026-06-15 22:08","pubTimestamp":1781532480,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/IRD/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 15, 2026 10:08 ET (14:08 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IRD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641140331","title":"Opus Genetics - Files for Resale of up to 2.68 Mln Shares of Common Stock by Selling Stockholders - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2641140331","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641140331?lang=en_us&edition=fundamental","pubTime":"2026-06-06 04:33","pubTimestamp":1780691593,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260605:nFWN42D0B0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IRD","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640166683","title":"Opus Genetics Initiated at Buy by Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2640166683","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640166683?lang=en_us&edition=fundamental","pubTime":"2026-06-04 23:38","pubTimestamp":1780587480,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/IRD/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 04, 2026 11:38 ET (15:38 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IRD","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640159752","title":"Guggenheim Initiates Opus Genetics at Buy With $16 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2640159752","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640159752?lang=en_us&edition=fundamental","pubTime":"2026-06-04 18:28","pubTimestamp":1780568896,"startTime":"0","endTime":"0","summary":"Opus Genetics (IRD) has an average rating of buy and mean price target of $10.27, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","IRD","BK7129","BK4139","IRD.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640967575","title":"Opus Genetics publishes investor presentation on gene therapy pipeline for rare inherited retinal diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2640967575","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640967575?lang=en_us&edition=fundamental","pubTime":"2026-06-02 05:23","pubTimestamp":1780349031,"startTime":"0","endTime":"0","summary":"Opus Genetics outlined a seven-asset AAV gene therapy portfolio in inherited retinal diseases, with two programs in clinical trials.OPGx-BEST1 Phase 1/2 enrollment completed; final participant scheduled for dosing in May 2026; Cohort 1 3-month data expected September 2026.Sentinel OPGx-BEST1 participant showed no ocular inflammation or dose-limiting toxicities through 3 months, with a 12-letter BCVA gain.The same patient showed a 23% decrease in central subfield thickness in the treated eye over 3 months, indicating an early structural response.OPGx-LCA5 program cited Phase 1/2 safety and efficacy in adults and children, with RMAT, Orphan Drug, Rare Pediatric Disease designations.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Opus Gen","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nNDL7z5CFn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4139","IRD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639165986","title":"BRIEF-Opus Genetics Reports Inducement Grants Under Nasdaq Listing Rule","url":"https://stock-news.laohu8.com/highlight/detail?id=2639165986","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639165986?lang=en_us&edition=fundamental","pubTime":"2026-05-29 04:12","pubTimestamp":1779999124,"startTime":"0","endTime":"0","summary":"BRIEF-Opus Genetics Reports Inducement Grants Under Nasdaq Listing RuleMay 28 (Reuters) - Opus Genetics Inc IRD.O:OPUS GENETICS REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)Source text: ID:nGNX5jqLTCFurther company coverage: IRD.O ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260528:nTUABWGLZD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4139","IRD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639615281","title":"Opus Genetics grants options for 698,000 shares to 10 new hires under inducement plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2639615281","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639615281?lang=en_us&edition=fundamental","pubTime":"2026-05-29 04:02","pubTimestamp":1779998523,"startTime":"0","endTime":"0","summary":"Opus Genetics granted stock options covering 698,000 common shares to 10 newly hired non-executive employees under its 2021 Inducement Plan.Options carry an exercise price set at the shares’ fair market value on the grant date.Vesting runs four years: 25% on the first anniversary of the hire date, then the remainder in quarterly installments.Award terms include potential acceleration or forfeiture triggers under the applicable agreements.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260528:nNDL1pzfC0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2095319765.USD","IE00B64PRP62.GBP","IE00BGHQF748.EUR","LU0314104364.USD","IE00BN0W2T93.GBP","LU2210149790.SGD","LU2210150020.SGD","BK4585","BK4007","BK4588","SG9999014021.USD","IRD","NDAQ","SG9999014005.SGD","IE00BKPKM429.USD","IE00B3QW5Z07.USD","SG9999014013.SGD","BK4139","IE00BN0W2V16.EUR","IE00BN0W2W23.USD","BK4112","SG9999014039.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639464615","title":"Opus Genetics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2639464615","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639464615?lang=en_us&edition=fundamental","pubTime":"2026-05-29 04:01","pubTimestamp":1779998460,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260528:nTUABWGLZD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4007","IRD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638256507","title":"Opus Genetics presents at Jefferies Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2638256507","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638256507?lang=en_us&edition=fundamental","pubTime":"2026-05-27 20:03","pubTimestamp":1779883396,"startTime":"0","endTime":"0","summary":"Opus Genetics management will present at the Jefferies Global Healthcare Conference on June 3, 2026 at 8:45 a.m. ET.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Opus Genetics Inc. published the original content used to generate this news brief on May 27, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nNDL7XcHsh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4139","IRD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637331074","title":"Opus Genetics Initiated at Outperform by Leerink Partners","url":"https://stock-news.laohu8.com/highlight/detail?id=2637331074","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637331074?lang=en_us&edition=fundamental","pubTime":"2026-05-21 21:51","pubTimestamp":1779371460,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/IRD/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 21, 2026 09:51 ET (13:51 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IRD","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637380249","title":"Leerink Partners Initiates Opus Genetics at Outperform With $10 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2637380249","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637380249?lang=en_us&edition=fundamental","pubTime":"2026-05-21 19:11","pubTimestamp":1779361902,"startTime":"0","endTime":"0","summary":"Opus Genetics, Inc. (IRD) has an average rating of buy and mean price target of $10.27, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7129","IRD.AU","BK4007","BK4139","IRD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637382585","title":"Opus Genetics initiated with an Outperform at Leerink","url":"https://stock-news.laohu8.com/highlight/detail?id=2637382585","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637382585?lang=en_us&edition=fundamental","pubTime":"2026-05-21 18:17","pubTimestamp":1779358642,"startTime":"0","endTime":"0","summary":"Leerink analyst Lili Nsongo initiated coverage of Opus Genetics (IRD) with an Outperform rating and $10 price target Published first on TheFly – th...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/opus-genetics-initiated-with-an-outperform-at-leerink-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/opus-genetics-initiated-with-an-outperform-at-leerink-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","IRD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637384808","title":"Opus Genetics Inc : Leerink Partners Initiates Coverage With Outperform Rating; Target Price $10","url":"https://stock-news.laohu8.com/highlight/detail?id=2637384808","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637384808?lang=en_us&edition=fundamental","pubTime":"2026-05-21 18:03","pubTimestamp":1779357823,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nFWN41Y04S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","IRD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637714308","title":"Foundation Fighting Blindness Retinal Degeneration Fund sells Opus Genetics shares worth $7.4 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2637714308","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637714308?lang=en_us&edition=fundamental","pubTime":"2026-05-21 07:30","pubTimestamp":1779319820,"startTime":"0","endTime":"0","summary":"Foundation Fighting Blindness Retinal Degeneration Fund sold 1.7 million Opus Genetics common shares at USD 4.35 on May 18, 2026.Its stake fell to 3,792,171 shares following the sale.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Opus Genetics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 20, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260520:nNDL46189M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Foundation Fighting Blindness Retinal Degeneration Fund sells Opus Genetics shares worth $7.4 million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IRD","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635506652","title":"LifeSci Capital Sticks to Its Buy Rating for Opus Genetics (IRD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2635506652","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635506652?lang=en_us&edition=fundamental","pubTime":"2026-05-16 22:36","pubTimestamp":1778942214,"startTime":"0","endTime":"0","summary":"In a report released today, Francois Brisebois from LifeSci Capital maintained a Buy rating on Opus Genetics, with a price target of $10.00. Accord...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/lifesci-capital-sticks-to-its-buy-rating-for-opus-genetics-ird-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/lifesci-capital-sticks-to-its-buy-rating-for-opus-genetics-ird-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IRD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635717896","title":"Cantor Fitzgerald Sticks to Its Buy Rating for Opus Genetics (IRD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2635717896","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635717896?lang=en_us&edition=fundamental","pubTime":"2026-05-14 20:18","pubTimestamp":1778761133,"startTime":"0","endTime":"0","summary":"Cantor Fitzgerald analyst Steven Seedhouse maintained a Buy rating on Opus Genetics yesterday and set a price target of $15.00. The company’s share...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/cantor-fitzgerald-sticks-to-its-buy-rating-for-opus-genetics-ird-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/cantor-fitzgerald-sticks-to-its-buy-rating-for-opus-genetics-ird-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IRD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635769348","title":"Opus Genetics (IRD) Q1 Loss Of US$65.5 Million Intensifies Bearish Community Narratives","url":"https://stock-news.laohu8.com/highlight/detail?id=2635769348","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635769348?lang=en_us&edition=fundamental","pubTime":"2026-05-14 10:27","pubTimestamp":1778725633,"startTime":"0","endTime":"0","summary":"Opus Genetics (IRD) opened Q1 2026 with revenue of US$2.2 million and a basic EPS loss of US$0.75, putting a clear focus on how much cash the business is burning to support its growth plans. The company has reported quarterly revenue between US$2.9 million and US$4.4 million over the past five periods, while basic EPS losses have ranged from US$0.12 to US$1.16, giving investors a broad view of how the income statement changes as spending shifts. With profitability still some way off and...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ird/opus-genetics/news/opus-genetics-ird-q1-loss-of-us655-million-intensifies-beari","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ird/opus-genetics/news/opus-genetics-ird-q1-loss-of-us655-million-intensifies-beari","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IRD","BK7129","IRD.AU","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":4,"totalSize":121,"code":"91000000","status":"200"}]}}